1. HBW Insight

VMS Market Regulation Gets Targeted Funding In US FDA Budget; OTC Switches Get Question

 
• By Malcolm Spicer

In report explaining congressional intent for omnibus spending bill, House and Senate appropriators note concerns about, and target $5m for, regulation of supplement market. Question on moving drug ingredients from Rx to nonprescription not accompanied by targeted funding.

• Source: Alamy

US lawmakers are concerned about both the prevalence of adulterated dietary supplements the US marketplace and the lack of additional drugs being made available OTC. One of the problems got targeted funding in the fiscal year 2022 appropriation for federal agencies.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Regulation

More from Policy & Regulation